Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
Mushtaq MU, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, Shune L, Abdallah AO, Abhyankar SH, McGuirk JP, Singh AK.
Leuk Lymphoma. 2024 Apr;65(4):493-502. doi: 10.1080/10428194.2023.2300708. Epub 2024 Jan 2.
PMID:38164945
Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.
Seftel MD, Musto G, Allan D, Bucher O, Hay K, Pasic I, Truong T, Paulson K.
Curr Oncol. 2024 Dec 27;32(1):10. doi: 10.3390/curroncol32010010.
PMID:39851926
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.